The price of patented cancer drugs in the USA rises steadily after their launch, according to a study by Noa Gordon (Rabin Medical Centre, Petah Tikva, Israel) and colleagues. The researchers calculated the monthly, annual, and cumulative changes in the cost of 24 patented injectable cancer medications that obtained US Food and Drug Administration (FDA) approval between 1996 and 2012.

中文翻译：

---

美国癌症药物成本上升

根据Noa Gordon（以色列Petah Tikva的Rabin医疗中心）及其同事的一项研究，在美国，专利癌症药物的价格在投放市场后稳步上升。研究人员计算了1996年至2012年间获得美国食品和药物管理局（FDA）批准的24种专利可注射抗癌药物的价格的每月，年度和累计变化。